BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
- Resource Type
- Article
- Authors
- Coussy, Florence; El-Botty, Rania; Château-Joubert, Sophie; Dahmani, Ahmed; Montaudon, Elodie; Leboucher, Sophie; Morisset, Ludivine; Painsec, Pierre; Sourd, Laura; Huguet, Léa; Nemati, Fariba; Servely, Jean-Luc; Larcher, Thibaut; Vacher, Sophie; Briaux, Adrien; Reyes, Cécile; La Rosa, Philippe; Lucotte, Georges; Popova, Tatiana; Foidart, Pierre
- Source
- Science Translational Medicine; 2/19/2020, Vol. 12 Issue 531, p1-12, 12p
- Subject
- TRIPLE-negative breast cancer
DNA topoisomerase I
- Language
- ISSN
- 19466234